Clinical Trial Update: Efficacy & Safety of ViaDerm-hPTH(1-34) Compared to Forteo SC in Postmenopausal Women With Osteoporosis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing ViaDerm-hPTH(1-34) to Forteo (teriparatide) in postmenopausal osteoporosis provides efficacy and safety data.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Forteo (teriparatide)
• ViaDerm-hPTH(1-34) (hPTH(1-34))

Snippet

Sponsor: TransPharma Medical | Conditions: Osteoporosis | Phase 2 | Status: COMPLETED